205 related articles for article (PubMed ID: 35189470)
21. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets.
Yang J; Xu J; Wang W; Zhang B; Yu X; Shi S
Signal Transduct Target Ther; 2023 May; 8(1):210. PubMed ID: 37217462
[TBL] [Abstract][Full Text] [Related]
22. Regulatory mechanisms and clinical applications of tumor-driven exosomal circRNAs in cancers.
Meng X; Yang D; Zhang B; Zhao Y; Zheng Z; Zhang T
Int J Med Sci; 2023; 20(6):818-835. PubMed ID: 37213665
[TBL] [Abstract][Full Text] [Related]
23. EIF4A3 serves as a prognostic and immunosuppressive microenvironment factor and inhibits cell apoptosis in bladder cancer.
Hu B; Chen R; Jiang M; Xiong S; Liu X; Fu B
PeerJ; 2023; 11():e15309. PubMed ID: 37180585
[TBL] [Abstract][Full Text] [Related]
24. Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion.
Hao C; Sheng Z; Wang W; Feng R; Zheng Y; Xiao Q; Zhang B
Thorac Cancer; 2023 Jun; 14(16):1477-1491. PubMed ID: 37144254
[TBL] [Abstract][Full Text] [Related]
25. Exosomal Non-Coding RNAs: Novel Regulators of Macrophage-Linked Intercellular Communication in Lung Cancer and Inflammatory Lung Diseases.
Lai X; Zhong J; Zhang B; Zhu T; Liao R
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979471
[TBL] [Abstract][Full Text] [Related]
26. Regulation of the tumor immune microenvironment by cancer-derived circular RNAs.
Guan L; Hao Q; Shi F; Gao B; Wang M; Zhou X; Han T; Ren W
Cell Death Dis; 2023 Feb; 14(2):132. PubMed ID: 36797245
[TBL] [Abstract][Full Text] [Related]
27. Exosomal ncRNAs facilitate interactive 'dialogue' between tumor cells and tumor-associated macrophages.
Zhou X; Liu Q; Wang X; Yao X; Zhang B; Wu J; Sun C
Cancer Lett; 2023 Jan; 552():215975. PubMed ID: 36306940
[TBL] [Abstract][Full Text] [Related]
28. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
[TBL] [Abstract][Full Text] [Related]
29. Phosphoinositide 3-kinase/Akt and its related signaling pathways in the regulation of tumor-associated macrophages polarization.
Yang D; Yang L; Cai J; Li H; Xing Z; Hou Y
Mol Cell Biochem; 2022 Oct; 477(10):2469-2480. PubMed ID: 35590082
[TBL] [Abstract][Full Text] [Related]
30. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis.
Zhang LX; Gao J; Long X; Zhang PF; Yang X; Zhu SQ; Pei X; Qiu BQ; Chen SW; Lu F; Lin K; Xu JJ; Wu YB
Mol Cancer; 2022 May; 21(1):110. PubMed ID: 35525959
[TBL] [Abstract][Full Text] [Related]
31. Novel insights into the roles of migrasome in cancer.
Deng S; Wu Y; Huang S; Yang X
Discov Oncol; 2024 May; 15(1):166. PubMed ID: 38748047
[TBL] [Abstract][Full Text] [Related]
32. Dumbbell Dual-Hairpin Triggered DNA Nanonet Assembly for Cascade-Amplified Sensing of Exosomal MicroRNA.
Li Y; Tang X; Deng R; Feng L; Xie S; Chen M; Zheng J; Chang K
ACS Omega; 2024 Apr; 9(17):19723-19731. PubMed ID: 38708273
[TBL] [Abstract][Full Text] [Related]
33. Unfolding the Complexity of Exosome-Cellular Interactions on Tumour Immunity and Their Clinical Prospects in Nasopharyngeal Carcinoma.
Chak PT; Kam NW; Choi TH; Dai W; Kwong DL
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473281
[TBL] [Abstract][Full Text] [Related]
34. Revving the engine: PKB/AKT as a key regulator of cellular glucose metabolism.
Li X; Hu S; Cai Y; Liu X; Luo J; Wu T
Front Physiol; 2023; 14():1320964. PubMed ID: 38264327
[TBL] [Abstract][Full Text] [Related]
35. Roles of circRNA dysregulation in esophageal squamous cell carcinoma tumor microenvironment.
Li J; Song Y; Cai H; Zhou B; Ma J
Front Oncol; 2023; 13():1153207. PubMed ID: 37384299
[TBL] [Abstract][Full Text] [Related]
36. Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment.
Tan S; Yang Y; Yang W; Han Y; Huang L; Yang R; Hu Z; Tao Y; Liu L; Li Y; Oyang L; Lin J; Peng Q; Jiang X; Xu X; Xia L; Peng M; Wu N; Tang Y; Cao D; Liao Q; Zhou Y
J Exp Clin Cancer Res; 2023 Mar; 42(1):59. PubMed ID: 36899389
[TBL] [Abstract][Full Text] [Related]
37. Unraveling the significance of exosomal circRNAs in cancer therapeutic resistance.
Kang F; Yan Y; Liu Y; Liang Q; Xu Z; Zhu W; Thakur A
Front Pharmacol; 2023; 14():1093175. PubMed ID: 36874026
[TBL] [Abstract][Full Text] [Related]
38. Tumor-derived or non-tumor-derived exosomal noncodingRNAs and signaling pathways in tumor microenvironment.
Wu Y; Niu D; Deng S; Lei X; Xie Z; Yang X
Int Immunopharmacol; 2022 May; 106():108626. PubMed ID: 35189470
[TBL] [Abstract][Full Text] [Related]
39. Exosomal Non-coding RNAs-Mediated Crosstalk in the Tumor Microenvironment.
Chen Q; Li Y; Liu Y; Xu W; Zhu X
Front Cell Dev Biol; 2021; 9():646864. PubMed ID: 33912560
[TBL] [Abstract][Full Text] [Related]
40. Crosstalk of Exosomal Non-Coding RNAs in The Tumor Microenvironment: Novel Frontiers.
Jia Z; Jia J; Yao L; Li Z
Front Immunol; 2022; 13():900155. PubMed ID: 35663957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
